Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions. The Advanced Therapies segment offers advanced therapy products, services, and solutions to the therapy departments of healthcare providers. The Diagnostics segment provides diagnostic products and services, including a range of testing applications, in the areas of laboratory, point of care, and molecular diagnostics. Siemens Healthineers AG is based in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
Industry, Sector and Symbol
Stock Exchange ETR
Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolETR:SHL
Previous Symbol
CUSIPN/A
Phone49 69 6682 6602
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
Siemens Healthineers (ETR:SHL) Frequently Asked Questions
What is Siemens Healthineers' stock symbol?
Siemens Healthineers trades on the ETR under the ticker symbol "SHL."
What price target have analysts set for SHL?
19 Wall Street analysts have issued 12-month price objectives for Siemens Healthineers' shares. Their predictions range from €33.50 to €43.00. On average, they anticipate Siemens Healthineers' share price to reach €38.37 in the next year. This suggests a possible upside of 5.2% from the stock's current price. View Analyst Price Targets for Siemens Healthineers.
What is the consensus analysts' recommendation for Siemens Healthineers?
19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 14 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Siemens Healthineers.
Has Siemens Healthineers been receiving favorable news coverage?
Headlines about SHL stock have trended positive this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Siemens Healthineers earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term.
Who are some of Siemens Healthineers' key competitors?
Some companies that are related to Siemens Healthineers include 3D Signatures (DXD), BioNano Genomics (BNGOU), Cambridge Cognition (COG), Carl Data Solutions (CRL), Carl Zeiss Meditec (AFX), Co-Diagnostics (CODX), Deepmatter Group (DMTR), EPIGENOMICS AG/S (EPGNY), Eternity Healthcare (ETAH), Genedrive (GDR), GeneNews (GEN), Imaging Dynamics (IDL), LED Medical Diagnostics (LMD), Lexagene (LXG) and MaxCyte (MXCT).
Who are Siemens Healthineers' key executives?
Siemens Healthineers' management team includes the folowing people:
- Dr. Jochen Schmitz, CFO & Member of Management Board (Age 52)
- Mr. Michael Reitermann, Chief Markets & Diagnostics Officer and Member of Management Board (Age 56)
- Mr. Florian Flossmann, Head of Investor Relations
What is Siemens Healthineers' stock price today?
One share of SHL stock can currently be purchased for approximately €36.49.
What is Siemens Healthineers' official website?
How can I contact Siemens Healthineers?
The company can be reached via phone at 49 69 6682 6602.
MarketBeat Community Rating for Siemens Healthineers (ETR SHL)
MarketBeat's community ratings are surveys of what our community members think about Siemens Healthineers and other stocks. Vote "Outperform" if you believe SHL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SHL will underperform the S&P 500 over the long term. You may vote once every thirty days.
